Northwestern Mutual Wealth Management
HEPA

Northwestern Mutual Wealth Management’s Hepion Pharmaceuticals HEPA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7
Closed -$12K – 2515
2020
Q1 		$12K Buy
+7
New +$28K ﹤0.01% 1847

Other funds holding HEPA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northwestern Mutual Wealth Management's HEPA Position: Q2 2020 in Review

Northwestern Mutual Wealth Management sold out of Hepion Pharmaceuticals (HEPA) in Q2 2020, closing a stake of 7 shares — an estimated $12K sold.

Northwestern Mutual Wealth Management first reported a position in HEPA in Q1 2020 and held it in 1 quarter. The position peaked at $12K in Q1 2020. 5 funds tracked by Wall St. Rank hold HEPA as of Q2 2020.

  • Northwestern Mutual Wealth Management reported no remaining Hepion Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 7 Hepion Pharmaceuticals shares in Q2 2020, an estimated $12K.
  • Northwestern Mutual Wealth Management first reported a position in Hepion Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Hepion Pharmaceuticals position peaked at $12K in Q1 2020.
  • 5 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2020.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.